- Home
- SGLY vs GCTK Comparison
SGLY vs GCTK Comparison
Compare SGLY & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGLY
- GCTK
- Stock Information
- Founded
- SGLY 2001
- GCTK 2001
- Country
- SGLY United States
- GCTK United States
- Employees
- SGLY N/A
- GCTK N/A
- Industry
- SGLY
- GCTK Medical/Dental Instruments
- Sector
- SGLY
- GCTK Health Care
- Exchange
- SGLY Nasdaq
- GCTK Nasdaq
- Market Cap
- SGLY 4.1M
- GCTK 3.3M
- IPO Year
- SGLY 2008
- GCTK N/A
- Fundamental
- Price
- SGLY $0.93
- GCTK $5.72
- Analyst Decision
- SGLY
- GCTK
- Analyst Count
- SGLY 0
- GCTK 0
- Target Price
- SGLY N/A
- GCTK N/A
- AVG Volume (30 Days)
- SGLY 12.0K
- GCTK 81.7K
- Earning Date
- SGLY 08-26-2025
- GCTK 08-14-2025
- Dividend Yield
- SGLY N/A
- GCTK N/A
- EPS Growth
- SGLY N/A
- GCTK N/A
- EPS
- SGLY N/A
- GCTK N/A
- Revenue
- SGLY $2,172,036.00
- GCTK N/A
- Revenue This Year
- SGLY N/A
- GCTK N/A
- Revenue Next Year
- SGLY N/A
- GCTK N/A
- P/E Ratio
- SGLY N/A
- GCTK N/A
- Revenue Growth
- SGLY N/A
- GCTK N/A
- 52 Week Low
- SGLY $0.54
- GCTK $5.11
- 52 Week High
- SGLY $7.65
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- SGLY 40.41
- GCTK 42.45
- Support Level
- SGLY $0.92
- GCTK $5.64
- Resistance Level
- SGLY $1.00
- GCTK $5.98
- Average True Range (ATR)
- SGLY 0.04
- GCTK 0.37
- MACD
- SGLY -0.00
- GCTK -0.03
- Stochastic Oscillator
- SGLY 11.11
- GCTK 11.65
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.